BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Samsca (Tolvaptan) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Samsca (Tolvaptan)\, from ClinicalTrials.
 gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04782258-588@assetmemo.bio
DTSTAMP:20261121T005814Z
DTSTART;VALUE=DATE:20281228
DTEND;VALUE=DATE:20281229
SUMMARY:Samsca (Tolvaptan): Phase 3 readout est. (NCT04782258)
DESCRIPTION:Samsca (Tolvaptan)\, phase 3.\nStudy: A Study to See if Tolvapt
 an is Safe in Infants and Children Who at Enrollment Are 28 Days to Less T
 han 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD
 )\nEstimated primary completion: 28 December 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/tolvaptan#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT04782258
URL:https://assetmemo.bio/drug/tolvaptan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
